Palomino Laboratories (PALX) Change in Accured Expenses (2023 - 2025)

Palomino Laboratories' Change in Accured Expenses history runs 3 years deep, the most recent figure standing at $464910.0 for Q3 2025.

• In Q3 2025, Change in Accured Expenses rose 16486.16% year-over-year to $464910.0; the TTM figure through Sep 2025 stood at $458934.0 (up 2413.74% YoY), while the FY2024 annual figure was $5443.0, up 143.75% from the prior year.
• Change in Accured Expenses came in at $464910.0 for Q3 2025 at Palomino Laboratories, up from -$5035.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $464910.0 in Q3 2025 to a low of -$41256.0 in Q4 2024.
• A 3-year average of $59648.9 and a median of -$177.5 in 2024 frame the typical range for Change in Accured Expenses.
• On a YoY basis, Change in Accured Expenses climbed as much as 16486.16% in 2025 and fell as far as 59.44% in 2025.
• Palomino Laboratories' Change in Accured Expenses stood at -$28442.0 in 2023, then sank by 45.05% to -$41256.0 in 2024, then soared by 1226.89% to $464910.0 in 2025.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered $464910.0, -$5035.0, and $40315.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.

Peer Comparison